Skip to main content

GOLDMAN SACHS GROUP INC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 886982 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,871,632
-$3,001,658 QoQ
Shares Held
226,780
-48.4% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 156 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. RIGL ranks #161 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,871,632 226,780
2026-03-31 $11,873,290 439,101
2025-12-31 $28,776,533 671,878
2025-09-30 $20,880,201 737,035
2025-06-30 $3,413,522 182,249
2025-03-31 $1,069,936 59,474
2024-12-31 $2,807,846 166,935
2024-09-30 $746,108 46,113
2024-03-31 $606,032 409,482
2023-12-31 $742,017 511,737
2023-09-30 $632,033 585,217
2023-06-30 $662,588 513,635
2023-03-31 $650,533 492,829
2022-12-31 $608,812 405,875
2022-09-30 $2,860,210 2,423,908
2022-06-30 $2,189,853 1,937,924
2022-03-31 $1,873,742 626,670
2021-12-31 $4,725,797 1,783,320
2021-09-30 $8,542,431 2,353,287
2021-06-30 $8,608,051 1,983,422
2021-03-31 $5,501,246 1,608,552
2020-12-31 $10,165,469 2,904,420
2020-09-30 $2,238,566 932,736
2020-06-30 $597,951 326,750
2020-03-31 $3,472,251 2,225,802